Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Orencia® (abatacept) – New indication
June 30, 2017 – The FDA approved Bristol-Myers Squibb’s Orencia (abatacept) injection for the treatment of adult patients with active psoriatic arthritis (PsA).
